MedTrace Logo

Cumulative Live Birth After Double Stimulation Protocol Versus Antagonist Protocol for Poor Ovarian Responders

NCT05765968 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1198

Last updated 2023-03-14

No results posted yet for this study

Summary

To compare the difference in cumulative live birth rates within one year between double stimulations protocol and two-cycle antagonist protocol in poor ovarian responders.

Conditions

Interventions

PROCEDURE

Double Stimulation Protocol

cummulative live birth outcome after two cycles of in virto fertilization using double stimulation protocol, which refers to two cycles of ovarian stimulation in both follicular phase and luteal phase within the same menstrual cycle

PROCEDURE

Antagonist Stimulation Protocol

cummulative live birth outcome within no more than two cycles of in virto fertilization using classical antagonist protocol

Sponsors & Collaborators

  • Hunan Provincial Maternal and Child Health Care Hospital

    collaborator OTHER

  • Jinghua Hospital of Shenyang

    collaborator UNKNOWN

  • Xinjiang Jiayin Hospital

    collaborator UNKNOWN

  • The Affiliated Hospital of Inner Mongolia Medical University

    collaborator OTHER

  • Guangdong Second Provincial General Hospital

    collaborator OTHER

  • The Affiliated Hospital of Qingdao University

    collaborator OTHER

  • Wuhan Tongji Reproductive Medicine Hospital

    collaborator UNKNOWN

  • Reproductive & Genetic Hospital of CITIC-Xiangya

    collaborator OTHER

  • Shandong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2026-03-01
Completion
2026-04-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05765968 on ClinicalTrials.gov